Point prevalence study of antibiotic susceptibility of genital group B streptococcus isolated from near-term pregnant women in Calgary, Alberta

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 23, Issue 3, 2012, Pages 121-124

  Church, Deirdre ^a   Carson, Julie ^a   Gregson, Dan ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antibiotic resistance; Group B streptococcus; Neonatal sepsis

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATION; CANADA; CASE REPORT; DELIVERY; EPSILOMETER TEST; FEMALE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PELVIC EXAMINATION; PENICILLIN ALLERGY; PHENOTYPE; PREGNANT WOMAN; PREVALENCE; PROTEIN METHYLATION; RIBOSOME; STREPTOCOCCUS AGALACTIAE;

EID: 84866759089     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/876103     Document Type: Article

References (29)

1. Verani JR, L McGee, Schrag SJ. Prevention of perinatal group B streptococcal disease: Revised guidelines from CDC, 2010. Morb Mortal Wkly Rep 2010;59:1-31.
2. Verani JR, Schrag SJ. Group B streptococcal disease in infants: Progress in prevention and continued challenges. Clin Perinatol 2010;37:375-92.
3. Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: The NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011;96:F9-14.
4. Hamada S, Vearncombe M, McGeer A, Shah PS. Neonatal group B streptococcal disease: Incidence, presentation, and mortality. J Matern Fetal Neonatal Med 2008;21:53-7.
5. Edwards MS, Baker CJ. Group B streptococcal infections. In: Remington JA, ed. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: WB Saunders, 2001:1091-156.
6. Stoll BJ, Hansen NI, Sanchez PJ, et al. Early onset neonatal sepsis: The burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011;127:817-26.
7. Davies HD, Adair CE, Partlow ES, Sauve R, Low DE, McGeer A. Two-year survey of Alberta laboratories processing of antenatal group B streptococcal (GBS) screening specimens: Implications for GBS screening programs. Diagn Microbiol Infect Dis 1999;35:169-76.
8. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20. (Pubitemid 30020655)
9. Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J 2011;30:937-41.
10. Powers RJ, Wirtschafter D. Prevention of group B Streptococcus early-onset disease: A toolkit by the California Perinatal Quality Care Collaborative. J Perinatol 2010;30:77-87.
11. Illuzzi JL, Bracken MB. Duration of intrapartum prophylaxis for neonatal group B streptococcal disease: A systematic review. Obstet Gynecol 2006;108:1254-65. (Pubitemid 44665425)
12. Money DM, Dobson S. The prevention of early-onset neonatal group B streptococcal disease. J Obstet Gynaecol Can 2004;26:826-40.
13. Clinical Laboratory Standards Institute (CLSI). Performance Standard for Antibiotic Susceptibility Testing; 21st Informational Supplement. M100-S21. Wayne: The Institute, 2011.
14. Church DL, Baxter H, Lloyd T, Miller B, Elsayed S. Evaluation of StrepB carrot broth versus Lim broth for detection of group B Streptococcus colonization status of near-term pregnant women. J Clin Microbiol 2008;46:2780-2.
15. Woods CR. Macrolide-inducible resistance to clindamycin and the D-test. Pediatr Infect Dis J 2009;28:1115-8.
16. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin Infect Dis 2002;34:482-92. (Pubitemid 34112269)
17. Balikova D, Adamkova V, Svobodova J. [High resistance of bacterial strains Streptococcus agalactiae to antibiotic therapy in early-onset and late-onset disease in newborns]. Ceska Gynekol 2011;76:235-9.
18. DiPersio LP, DiPersio JR. High rates of erythromycin and clindamycin resistance among OBGYN isolates of group B Streptococcus. Diagn Microbiol Infect Dis 2006;54:79-82. (Pubitemid 41815192)
19. Garland SM, Cottrill E, Markowski L, et al. Antimicrobial resistance in group B streptococcus: The Australian experience. J Med Microbiol. 2011;60:230-5.
20. Zhao Z, Kong F, Zeng X, Gidding HF, Morgan J, Gilbert GL. Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australasian patients belonging to different age groups. Clin Microbiol Infect 2008;14:260-7. (Pubitemid 351201017)
21. Gygax SE, Schuyler JA, Kimmel LE, Trama JP, Mordechai E, Adelson ME. Erythromycin and clindamycin resistance in group B streptococcal clinical isolates. Antimicrob Agents Chemother 2006;50:1875-7.
22. Clifford V, Heffernan HM, Grimwood K, Garland S. Variation in erythromycin and clindamycin resistance patterns between New Zealand and Australian group B streptococcus isolates. Aust N Z J Obstet Gynaecol 2011;51:328-32.
23. Pinheiro S, Radhouani H, Coelho C, et al. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women. Microb Drug Resist 2009;15:121-4.
24. Panda B, Iruretagoyena I, Stiller R, Panda A. Antibiotic resistance and penicillin tolerance in ano-vaginal group B streptococci. J Matern Fetal Neonatal Med 2009;22:111-4.
25. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000;107:770-5. (Pubitemid 30311914)
26. Chen KT, Puopolo KM, Eichenwald EC, Onderdonk AB, Lieberman E. No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis. Am J Obstet Gynecol 2005;192:1167-71. (Pubitemid 40487795)
27. Valenstein P, Meier F. Outpatient order accuracy. A College of American Pathologists Q-Probes study of requisition order entry accuracy in 660 institutions. Arch Pathol Lab Med 1999;123:1145-50.
28. Laiprasert J, Klein K, Mueller BA, Pearlman MD. Transplacental passage of vancomycin in noninfected term pregnant women. Obstet Gynecol 2007;109:1105-10. (Pubitemid 46685953)
29. Hnat MD, Gainer J, Bawdon RE, Wendel GD Jr. Transplacental passage of vancomycin in the ex vivo human perfusion model. Infect Dis Obstet Gynecol 2004;12:57-61. (Pubitemid 40017520)